Department of Cancer Biology, City of Hope Beckman Research Institute and Medical Center, Duarte, CA 91010, USA; Department of Pharmacology, College of Pharmacy, The Third Military Medical University, Chongqing, 400038, China.
Department of Cancer Biology, City of Hope Beckman Research Institute and Medical Center, Duarte, CA 91010, USA.
Cancer Cell. 2014 Apr 14;25(4):501-15. doi: 10.1016/j.ccr.2014.03.007.
Cancer-secreted microRNAs (miRNAs) are emerging mediators of cancer-host crosstalk. Here we show that miR-105, which is characteristically expressed and secreted by metastatic breast cancer cells, is a potent regulator of migration through targeting the tight junction protein ZO-1. In endothelial monolayers, exosome-mediated transfer of cancer-secreted miR-105 efficiently destroys tight junctions and the integrity of these natural barriers against metastasis. Overexpression of miR-105 in nonmetastatic cancer cells induces metastasis and vascular permeability in distant organs, whereas inhibition of miR-105 in highly metastatic tumors alleviates these effects. miR-105 can be detected in the circulation at the premetastatic stage, and its levels in the blood and tumor are associated with ZO-1 expression and metastatic progression in early-stage breast cancer.
癌症分泌的 microRNAs(miRNAs)是癌症与宿主细胞相互作用的新兴介质。在这里,我们发现特征性表达和分泌于转移性乳腺癌细胞的 miR-105 通过靶向紧密连接蛋白 ZO-1 成为迁移的有效调控因子。在血管内皮细胞单层中,癌症分泌的 miR-105 通过外泌体介导的转移,有效地破坏了紧密连接和这些天然屏障对转移的完整性。在非转移性癌细胞中过表达 miR-105 会诱导远处器官的转移和血管通透性,而在高度转移性肿瘤中抑制 miR-105 则会减轻这些作用。miR-105 可以在转移前阶段的循环中被检测到,其在血液和肿瘤中的水平与 ZO-1 表达和早期乳腺癌的转移进展相关。